论文部分内容阅读
作为中国重要的化工工业基地,上海拥有国内最大的化工企业群体,并已成为拜耳在中国的投资重点。上海化学工业区位于集中了全国38%化工企业的长江三角洲,其总资产已经从1993年的519亿人民币上升到1998年的1540亿人民币。拜耳正以一项大型一体化化工基地的建设项目积极投身于这样迅猛的发展之中。该项目计划总投资达31亿美元,其中包括一家将于2003年投入运营的世界级规模的聚碳酸酯生产厂。目前,拜耳在中国已建有11家生产性企业,产品覆盖其四大核心领域:高分子聚合物、医药保健、农业和化学品。总投资额已达2.82亿美元。在中国,拜耳将自己的未来定位于上海。在中国即将加入WTO,并将最终给予大陆的外国公司经销权之际,拜耳计划将现在香港的中国地区总部迁往上海。拜耳是全球领先的化工及医药保健集团之一,年销售额以及
As an important chemical industrial base in China, Shanghai has the largest group of chemical companies in China and has become Bayer’s investment focus in China. Shanghai Chemical Industry Park is located in the Yangtze River Delta, where 38% of China’s chemical companies are concentrated. Its total assets have risen from 51.9 billion yuan in 1993 to 154 billion yuan in 1998. Bayer is actively participating in such a rapid development with a large-scale integrated chemical base construction project. The project plans a total investment of 3.1 billion U.S. dollars, including a world-scale polycarbonate production plant that will be put into operation in 2003. At present, Bayer has established 11 production enterprises in China and its products cover its four core areas: polymer, medical care, agriculture and chemicals. The total investment has reached 282 million US dollars. In China, Bayer has positioned itself in Shanghai. While China is about to join the WTO and will eventually give the rights of distribution to foreign companies on the mainland, Bayer plans to relocate its current regional headquarters in Hong Kong to Shanghai. Bayer is one of the world’s leading chemical and pharmaceutical health groups with annual sales and